Compared with men, women may have a worse prognosis after native coronary r
evascularization. However, the influence of gender on clinical outcomes aft
er saphenous vein graft (SVG) stenting is unknown. The purpose of this stud
y was to compare early and 1-year clinical outcomes between men and women a
fter stent implantation in SVG. A total of 1,199 consecutive patients with
1,858 SVG lesions were studied. Procedural success, in-hospital events, and
late clinical outcomes were compared between men (n = 951) and women (n =
248). Overall procedural success was similar between men and women (97% vs
96%, p = NS). However, in-hospital (3.2% vs 1.6%, p = 0.07) and 30-day cumu
lative (4.4% vs 1.9%, p = 0.02) mortality rates were higher in women than i
n men. In addition, women had a higher incidence of vascular complications
(12% vs 7.3%, p 0.006) and postprocedural acute renal failure (8.1% vs 4%,
p = 0.02). At 1-year follow-up, mortality was 13% in women and 11% in men (
p = NS) and target lesion revascularization was 18% versus 23%, respectivel
y (p = NS). By multivariate regression analysis, independent correlates of
in-hospital mortality were female gender (odds ratio [OR] 3.6, confidence i
nterval [Ct] 1.0 to 12.5, p = 0.05) and left ventricular ejection fraction
(OR 0.9, Cl 0.9 to 1.0, p = 0.01). Female gender was found to predict 30-da
y mortality (OR 2.5, CI 1.1 to 5.5, p 0.02). The sole predictor of 1-year m
ortality was diabetes mellitus (OR 1.6, Cl 1.1 to 2.3, p = 0.01). This stud
y shows that women compared with men treated with stent implantation in SVG
lesions have (1) a trend toward higher in-hospital mortality, (2) higher r
isk of 30-day mortality, (3) increased incidence of vascular complications
and postprocedure acute renal failure, and (4) similar 1-year clinical outc
ome. (C) 2001 by Excerpta Medica, Inc.